CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $728,000 | -91.6% | 25,888 | -83.9% | 0.00% | -90.9% |
Q3 2021 | $8,707,000 | -28.5% | 161,276 | -55.7% | 0.01% | -26.7% |
Q2 2021 | $12,173,000 | +9.1% | 364,027 | -32.8% | 0.02% | +7.1% |
Q1 2021 | $11,153,000 | -39.3% | 541,427 | -48.4% | 0.01% | -30.0% |
Q4 2020 | $18,375,000 | -28.7% | 1,048,827 | -39.6% | 0.02% | -23.1% |
Q3 2020 | $25,755,000 | +21.0% | 1,736,675 | +6.1% | 0.03% | +44.4% |
Q2 2020 | $21,283,000 | +995.4% | 1,637,175 | +39.9% | 0.02% | +800.0% |
Q1 2020 | $1,943,000 | -21.9% | 1,170,187 | +4.9% | 0.00% | 0.0% |
Q4 2019 | $2,487,000 | +13.8% | 1,115,368 | +8.7% | 0.00% | 0.0% |
Q3 2019 | $2,186,000 | -10.6% | 1,026,285 | +12.5% | 0.00% | 0.0% |
Q2 2019 | $2,445,000 | -8.8% | 912,285 | +67.4% | 0.00% | 0.0% |
Q1 2019 | $2,682,000 | – | 545,106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |